NCT05492448View on ClinicalTrials.gov

Probiotic on Type 2 Diabetes and Chronic Obstruction Pulmonary Disease

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 19, 2022

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2025

Conditions
Type 2 DiabetesChronic Obstructive Pulmonary Disease
Interventions
DIETARY_SUPPLEMENT

Placebo

Subjects take one pack containing maltodextrin twice daily after breakfast and dinner.

DIETARY_SUPPLEMENT

L. salivarius AP-32 and L. reuteri GL-104

Subjects take one pack containing L. salivarius AP-32 and L. reuteri GL-104 twice daily after breakfast and dinner.

DIETARY_SUPPLEMENT

L. reuteri GL-104

Subjects take one pack containing L. reuteri GL-104 twice daily after breakfast and dinner.

Trial Locations (1)

74442

RECRUITING

Glac Biotech Co., Ltd., Tainan City

All Listed Sponsors
lead

Glac Biotech Co., Ltd

INDUSTRY